HSF1 and breast cancer: Quantitative analysis showed that the increase in ratio of phosphorylated HSF1 to total HSF1 after NVP-AUY922 treatment correlates with the resistance of breast cancer cell lines to Hsp90 inhibition (r = 0.718; p = 0.0161) (Fig 2B) (S2 Fig).